157 related articles for article (PubMed ID: 38428704)
1. Biological activities, Molecular mechanisms, and Clinical application of Naringin in Metabolic syndrome.
Chen J; Qin X; Chen M; Chen T; Chen Z; He B
Pharmacol Res; 2024 Apr; 202():107124. PubMed ID: 38428704
[TBL] [Abstract][Full Text] [Related]
2. Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action.
Alam MA; Subhan N; Rahman MM; Uddin SJ; Reza HM; Sarker SD
Adv Nutr; 2014 Jul; 5(4):404-17. PubMed ID: 25022990
[TBL] [Abstract][Full Text] [Related]
3. The Potential Role of Naringin and Naringenin as Nutraceuticals Against Metabolic Syndrome.
Massaro L; Raguzzini A; Aiello P; Valencia DV
Endocr Metab Immune Disord Drug Targets; 2023; 23(4):428-445. PubMed ID: 36043734
[TBL] [Abstract][Full Text] [Related]
4. Preclinical evidence for the pharmacological actions of naringin: a review.
Bharti S; Rani N; Krishnamurthy B; Arya DS
Planta Med; 2014 Apr; 80(6):437-51. PubMed ID: 24710903
[TBL] [Abstract][Full Text] [Related]
5. Naringenin and naringin in cardiovascular disease prevention: A preclinical review.
Heidary Moghaddam R; Samimi Z; Moradi SZ; Little PJ; Xu S; Farzaei MH
Eur J Pharmacol; 2020 Nov; 887():173535. PubMed ID: 32910944
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of naringin against drugs and chemical toxins induced hepatotoxicity: A review.
Shirani K; Yousefsani BS; Shirani M; Karimi G
Phytother Res; 2020 Aug; 34(8):1734-1744. PubMed ID: 32067280
[TBL] [Abstract][Full Text] [Related]
7. Naringin improves lipid metabolism in a tissue-engineered liver model of NAFLD and the underlying mechanisms.
Zhang X; Zhang Y; Gao W; Guo Z; Wang K; Liu S; Duan Z; Chen Y
Life Sci; 2021 Jul; 277():119487. PubMed ID: 33862107
[TBL] [Abstract][Full Text] [Related]
8. Bioactivity of naringin and related mechanisms.
Zhao Y; Liu S
Pharmazie; 2021 Aug; 76(8):359-363. PubMed ID: 34412734
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of citrus flavanones naringin and naringenin and their food sources on lipid metabolism: An update on bioavailability, pharmacokinetics, and mechanisms.
Yang Y; Trevethan M; Wang S; Zhao L
J Nutr Biochem; 2022 Jun; 104():108967. PubMed ID: 35189328
[TBL] [Abstract][Full Text] [Related]
10. Naringin ameliorates metabolic syndrome by activating AMP-activated protein kinase in mice fed a high-fat diet.
Pu P; Gao DM; Mohamed S; Chen J; Zhang J; Zhou XY; Zhou NJ; Xie J; Jiang H
Arch Biochem Biophys; 2012 Feb; 518(1):61-70. PubMed ID: 22198281
[TBL] [Abstract][Full Text] [Related]
11. An in vitro and in vivo study of a 4-herb formula on the management of diet-induced metabolic syndrome.
Wat E; Wang Y; Chan K; Law HW; Koon CM; Lau KM; Leung PC; Yan C; Lau CBS
Phytomedicine; 2018 Mar; 42():112-125. PubMed ID: 29655677
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of naringin: an overview.
Chen R; Qi QL; Wang MT; Li QY
Pharm Biol; 2016 Dec; 54(12):3203-3210. PubMed ID: 27564838
[TBL] [Abstract][Full Text] [Related]
13. Naringin: Cardioprotective properties and safety profile in diabetes treatment.
Yaseen HS; Zubair HM; Jamal A; Farrukh M; Mikrani R; Shaukat B; Hill JW; Rana R; Nazir A; Naveed M; Malik S
Fitoterapia; 2024 Jul; 176():106011. PubMed ID: 38740344
[TBL] [Abstract][Full Text] [Related]
14. Naringin prevents HIV-1 protease inhibitors-induced metabolic complications in vivo.
Nzuza S; Zondi S; Owira PMO
PLoS One; 2017; 12(11):e0183355. PubMed ID: 29121676
[TBL] [Abstract][Full Text] [Related]
15. A Comprehensive Systematic Review of the Effects of Naringenin, a Citrus-Derived Flavonoid, on Risk Factors for Nonalcoholic Fatty Liver Disease.
Naeini F; Namkhah Z; Ostadrahimi A; Tutunchi H; Hosseinzadeh-Attar MJ
Adv Nutr; 2021 Mar; 12(2):413-428. PubMed ID: 32879962
[TBL] [Abstract][Full Text] [Related]
16. Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD).
Qiu YY; Zhang J; Zeng FY; Zhu YZ
Pharmacol Res; 2023 Jun; 192():106786. PubMed ID: 37146924
[TBL] [Abstract][Full Text] [Related]
17. Naringin Protects against Non-Alcoholic Fatty Liver Disease by Promoting Autophagic Flux and Lipophagy.
Guan L; Guo L; Zhang H; Liu H; Zhou W; Zhai Y; Yan X; Men X; Peng L
Mol Nutr Food Res; 2024 Feb; 68(3):e2200812. PubMed ID: 38054638
[TBL] [Abstract][Full Text] [Related]
18. Emerging potential of citrus flavanones as an antioxidant in diabetes and its complications.
Sharma M; Akhtar N; Sambhav K; Shete G; Bansal AK; Sharma SS
Curr Top Med Chem; 2015; 15(2):187-95. PubMed ID: 25547100
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
20. A Review on the Pharmacokinetic Properties of Naringin and Its Therapeutic Efficacies in Respiratory Diseases.
Zeng X; Su W; Liu B; Chai L; Shi R; Yao H
Mini Rev Med Chem; 2020; 20(4):286-293. PubMed ID: 32134369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
